DPP4 and type 2 diabetes mellitus: Different classes of drugs include thiazolidinedione, dipeptidyl peptidase-4 (DPP-4) inhibitor, sodium-glucose linked transporter-2 inhibitor, GLP-1 receptor agonist, and basal insulin, target different pathways to address the multiple pathophysiology of T2DM.